Cullinan Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
October 3, 2017
Vertical
Oncology
Funding Amount
$150,000,000
Company Info
Market
Oncology therapeutics
Location
Cambridge, MA, USA
Coinvestors
F2 Ventures, MPM Capital
Company Description

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.